Measuring Treatment Response in Progressive Multiple Sclerosis—Considerations for Adapting to an Era of Multiple Treatment Options

Disability in multiple sclerosis accrues predominantly in the progressive forms of the disease. While disease-modifying treatment of relapsing MS has drastically evolved over the last quarter-century, the development of efficient drugs for preventing or at least delaying disability in progressive MS...

Descripción completa

Detalles Bibliográficos
Autores principales: Krajnc, Nik, Berger, Thomas, Bsteh, Gabriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470215/
https://www.ncbi.nlm.nih.gov/pubmed/34572555
http://dx.doi.org/10.3390/biom11091342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470215/
https://www.ncbi.nlm.nih.gov/pubmed/34572555
http://dx.doi.org/10.3390/biom11091342

Ejemplares similares